Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Kiwa Bio-Tech JV Will Develop Veterinary Anti-Viral Spray

publication date: May 27, 2008

Kiwa Bio-Tech Products Group Corporation has established a 70-30 joint venture in China with Hebei Huaxing Pharmaceuticals Co., Ltd. to develop AF-01 as a veterinary preventative for avian flu and other viral diseases. The new JV will be called Hebei Kiwa Huaxing Bio-Pharmaceuticals Co., Ltd. AF-01 will be developed as an aerosol broad-spectrum anti-viral that can be applied in fowl houses and other animal holding facilities to prevent the spread of virus-caused diseases. More details...

Stock Symbol: (OTCBB: KWBT)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital